Skip to main content
Clinical Trials/NCT04337567
NCT04337567
Unknown
Not Applicable

A Prospective Randomized Trial for the Comparison of Procedural Characteristics and Long-term Effects of Radiofrequency Ablation and Balloon Cryoablation in Elderly Patients With Atrial Fibrillation

Vivantes Netzwerk für Gesundheit GmbH1 site in 1 country80 target enrollmentMarch 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Atrial Fibrillation
Sponsor
Vivantes Netzwerk für Gesundheit GmbH
Enrollment
80
Locations
1
Primary Endpoint
atrial arrhythmia recurrence
Last Updated
6 years ago

Overview

Brief Summary

This study compares the procedural characteristics and effectivity of radiofrequency ablation and cryoablation in patients with atrial fibrillation that are 75 years or older.

Detailed Description

Radiofrequency and cryoballon ablation have been shown to be comparable to each other in terms of safety and effectivity in patients with atrial fibrillation. However, elderly patients have been underrepresented in the previous studies. The number of older patients with atrial fibrillation is high and the number of who undergo an ablation procedure for atrial fibrillation increases steadily. This prospective randomized trial compares the effectivity (recurrency of atrial arrhythmias) and periprocedural characteristics of the two established ablation methods in patients who are 75 years or older.

Registry
clinicaltrials.gov
Start Date
March 1, 2020
End Date
January 31, 2024
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Charalampos Kriatselis

Principal Investigator

Vivantes Netzwerk für Gesundheit GmbH

Eligibility Criteria

Inclusion Criteria

  • Patients with recurrent symptomatic paroxysmal or persistent atrial fibrillation
  • At the day of their inclusion in the study the patients have to have completed the 75th year of life

Exclusion Criteria

  • Presence of left atrial thrombus
  • Left atrial volume\> 50 ml/m²
  • Renal failure (GFR≤ 30 ml/min)
  • Comorbidity with an expected survival of 12 months or less.

Outcomes

Primary Outcomes

atrial arrhythmia recurrence

Time Frame: 1 year

Number of Participants with recurrence of any atrial arrhythmia with a duration of 30 sec or longer 12 months after the ablative treatment

Secondary Outcomes

  • procedural duration(periprocedural)
  • contrast medium dosis(periprocedural)
  • vascular complications(1 year)
  • Propofoldosis(periprocedural)
  • groin complications(up to 3 months after dismission from the hospital)
  • time to wake-up after propofol withdrawal(periprocedural)
  • Neurological complications(1 year)
  • duration of hospital staying [days](1 year)

Study Sites (1)

Loading locations...

Similar Trials